Skip to main content
Top
Published in: BMC Public Health 1/2018

Open Access 01-12-2018 | Research article

Care Cascade for targeted tuberculosis testing and linkage to Care in Homeless Populations in the United States: a meta-analysis

Authors: Andrea Parriott, Mohsen Malekinejad, Amanda P. Miller, Suzanne M. Marks, Hacsi Horvath, James G. Kahn

Published in: BMC Public Health | Issue 1/2018

Login to get access

Abstract

Background

Homelessness increases the risk of tuberculosis (TB) disease and latent TB infection (LTBI), but persons experiencing homelessness often lack access to testing and treatment. We assessed the yield of TB testing and linkage to care for programs targeting homeless populations in the United States.

Methods

We conducted a comprehensive search of peer-reviewed and grey literature, adapting Cochrane systematic review methods. Two reviewers independently assessed study eligibility and abstracted key data on the testing to care cascade: number of persons reached, recruited for testing, tested for LTBI, with valid test results, referred to follow-up care, and initiating care. We used random effects to calculate pooled proportions and 95% confidence intervals (CI) of persons retained in each step via inverse-variance weighted meta-analysis, and cumulative proportions as products of adjacent step proportions.

Results

We identified 23 studies published between 1986 and 2014, conducted in 12 states and 15 cities. Among studies using tuberculin skin tests (TST) we found that 93.7% (CI 72.4-100%) of persons reached were recruited, 97.9% (89.3-100%) of those recruited had tests placed, 85.5% (78.6-91.3%) of those with tests placed returned for reading, 99.9% (99.6-100%) of those with tests read had valid results, and 24.7% (21.0-28.5%) with valid results tested positive. All persons testing positive were referred to follow-up care, and 99.8% attended at least one session of follow-up care. Heterogeneity was high for most pooled proportions. For a hypothetical cohort of 1000 persons experiencing homelessness reached by a targeted testing program using TST, an estimated 917 were tested, 194 were positive, and all of these initiated follow-up care.

Conclusions

Targeted TB testing of persons experiencing homelessness appears effective in detecting LTBI and connecting persons to care and potential treatment. Future evaluations should assess diagnostic use of interferon gamma release assays and completion of treatment, and costs of testing and treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference United States Department of Housing and Urban Development. The 2015 annual homeless assessment report (AHAR) to congress. 2015. United States Department of Housing and Urban Development. The 2015 annual homeless assessment report (AHAR) to congress. 2015.
3.
go back to reference Bamrah S, Yelk Woodruff RS, Powell K, Ghosh S, Kammerer JS, Haddad MB. Tuberculosis among the homeless, United States, 1994-2010. Int J Tuberc Lung Dis. 2013;17:1414–9.CrossRefPubMedPubMedCentral Bamrah S, Yelk Woodruff RS, Powell K, Ghosh S, Kammerer JS, Haddad MB. Tuberculosis among the homeless, United States, 1994-2010. Int J Tuberc Lung Dis. 2013;17:1414–9.CrossRefPubMedPubMedCentral
4.
go back to reference Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2015. 2016. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2015. 2016.
5.
go back to reference Kushel MB, Vittinghoff E, Haas JS. Factors associated with the health care utilization of homeless persons. JAMA. 2001;285:200–6.CrossRefPubMed Kushel MB, Vittinghoff E, Haas JS. Factors associated with the health care utilization of homeless persons. JAMA. 2001;285:200–6.CrossRefPubMed
6.
go back to reference Wojtusik L, White MC. Health status, needs, and health care barriers among the homeless. J Health Care Poor Underserved. 1998;9:140–52.CrossRefPubMed Wojtusik L, White MC. Health status, needs, and health care barriers among the homeless. J Health Care Poor Underserved. 1998;9:140–52.CrossRefPubMed
8.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.CrossRefPubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.CrossRefPubMedPubMedCentral
10.
go back to reference Beijer U, Wolf A, Fazel S. Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:859–70.CrossRefPubMedPubMedCentral Beijer U, Wolf A, Fazel S. Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:859–70.CrossRefPubMedPubMedCentral
11.
go back to reference Alexander S. Engaging community stakeholders to control a homeless shelter outbreak in Indiana. TB Notes. 2011:7–10. Alexander S. Engaging community stakeholders to control a homeless shelter outbreak in Indiana. TB Notes. 2011:7–10.
12.
go back to reference Lashley M. A targeted testing program for tuberculosis control and prevention among Baltimore City's homeless population. Public Health Nurs. 2007;24:34–9.CrossRefPubMed Lashley M. A targeted testing program for tuberculosis control and prevention among Baltimore City's homeless population. Public Health Nurs. 2007;24:34–9.CrossRefPubMed
13.
go back to reference Cheung RC, Hanson AK, Maganti K, Keeffe EB, Matsui SM. Viral hepatitis and other infectious diseases in a homeless population. J Clin Gastroenterol. 2002;34:476–80.CrossRefPubMed Cheung RC, Hanson AK, Maganti K, Keeffe EB, Matsui SM. Viral hepatitis and other infectious diseases in a homeless population. J Clin Gastroenterol. 2002;34:476–80.CrossRefPubMed
14.
15.
go back to reference Barry MA, Wall C, Shirley L. Tuberculosis screening in Boston's homeless shelters. Public Health Rep. 1986;101:487–94.PubMedPubMedCentral Barry MA, Wall C, Shirley L. Tuberculosis screening in Boston's homeless shelters. Public Health Rep. 1986;101:487–94.PubMedPubMedCentral
16.
go back to reference Gelberg L, Panarites CJ, Morgenstern H, Leake B, Andersen RM, Koegel P. Tuberculosis skin testing among homeless adults. J Gen Intern Med. 1997;12:25–33.CrossRefPubMedPubMedCentral Gelberg L, Panarites CJ, Morgenstern H, Leake B, Andersen RM, Koegel P. Tuberculosis skin testing among homeless adults. J Gen Intern Med. 1997;12:25–33.CrossRefPubMedPubMedCentral
17.
go back to reference Paul EA, Lebowitz SM, Moore RE, Hoven CW, Bennett BA, Chen A. Nemesis revisited: tuberculosis infection in a new York City men's shelter. Am J Public Health. 1993;83:1743–5.CrossRefPubMedPubMedCentral Paul EA, Lebowitz SM, Moore RE, Hoven CW, Bennett BA, Chen A. Nemesis revisited: tuberculosis infection in a new York City men's shelter. Am J Public Health. 1993;83:1743–5.CrossRefPubMedPubMedCentral
18.
go back to reference Sakai J, Kim M, Shore J, Hepfer M. The risk of purified protein derivative positivity in homeless men with psychotic symptoms. South Med J. 1998;91:345–8.CrossRefPubMed Sakai J, Kim M, Shore J, Hepfer M. The risk of purified protein derivative positivity in homeless men with psychotic symptoms. South Med J. 1998;91:345–8.CrossRefPubMed
19.
go back to reference Neims SR, Fantry LE, Lee EU. Tuberculin positivity among the homeless. J Health Care Poor Underserved. 1992;3:263–9.CrossRefPubMed Neims SR, Fantry LE, Lee EU. Tuberculin positivity among the homeless. J Health Care Poor Underserved. 1992;3:263–9.CrossRefPubMed
20.
go back to reference Forman PD, Kinney C. Evaluation of a tuberculosis screening questionnaire for use in an Alaskan homeless population. Alaska Med. 2003;45:94–101.PubMed Forman PD, Kinney C. Evaluation of a tuberculosis screening questionnaire for use in an Alaskan homeless population. Alaska Med. 2003;45:94–101.PubMed
21.
go back to reference McAdam JM, Brickner PW, Scharer LL, Crocco JA, Duff AE. The spectrum of tuberculosis in a new York City men's shelter clinic (1982-1988). Chest. 1990;97:798–805.CrossRefPubMed McAdam JM, Brickner PW, Scharer LL, Crocco JA, Duff AE. The spectrum of tuberculosis in a new York City men's shelter clinic (1982-1988). Chest. 1990;97:798–805.CrossRefPubMed
22.
go back to reference Morrow R, Fanta J, Kerlen S. Tuberculosis screening and anergy in a homeless population. J Am Board Fam Pract. 1997;10:1–5.PubMed Morrow R, Fanta J, Kerlen S. Tuberculosis screening and anergy in a homeless population. J Am Board Fam Pract. 1997;10:1–5.PubMed
23.
go back to reference Griffin RG, Hoff GL. Tuberculosis screening in Kansas City homeless shelters. Mo Med. 1999;96:496–9.PubMed Griffin RG, Hoff GL. Tuberculosis screening in Kansas City homeless shelters. Mo Med. 1999;96:496–9.PubMed
24.
go back to reference Torres RA, Mani S, Altholz J, Brickner PW. Human immunodeficiency virus infection among homeless men in a new York City shelter. Association with Mycobacterium tuberculosis infection. Arch Intern Med. 1990;150:2030–6.CrossRefPubMed Torres RA, Mani S, Altholz J, Brickner PW. Human immunodeficiency virus infection among homeless men in a new York City shelter. Association with Mycobacterium tuberculosis infection. Arch Intern Med. 1990;150:2030–6.CrossRefPubMed
25.
go back to reference Nolan CM, Elarth AM, Barr H, Saeed AM, Risser DR. An outbreak of tuberculosis in a shelter for homeless men. A description of its evolution and control. Am Rev Respir Dis. 1991;143:257–61.CrossRefPubMed Nolan CM, Elarth AM, Barr H, Saeed AM, Risser DR. An outbreak of tuberculosis in a shelter for homeless men. A description of its evolution and control. Am Rev Respir Dis. 1991;143:257–61.CrossRefPubMed
26.
go back to reference Valencia E, Saez H. Assessment of TB screening inclusion in time-limited case management for hard-to-reach severe mentally ill individuals at risk for HIV: TB screening and critical time intervention (CTI) in new York City. XV International Aids Conference: Social and Economical Issues; 2004. p. 343–7. Valencia E, Saez H. Assessment of TB screening inclusion in time-limited case management for hard-to-reach severe mentally ill individuals at risk for HIV: TB screening and critical time intervention (CTI) in new York City. XV International Aids Conference: Social and Economical Issues; 2004. p. 343–7.
27.
go back to reference Dewan PK, Grinsdale J, Liska S, Wong E, Fallstad R, Kawamura LM. Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay. BMC Infect Dis. 2006;6:47.CrossRefPubMedPubMedCentral Dewan PK, Grinsdale J, Liska S, Wong E, Fallstad R, Kawamura LM. Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay. BMC Infect Dis. 2006;6:47.CrossRefPubMedPubMedCentral
28.
go back to reference Higashi J. Programmatic experience with IGRA testing: San Francisco. Boston, MA: North America Regional IUATLD Conference; 2014. Higashi J. Programmatic experience with IGRA testing: San Francisco. Boston, MA: North America Regional IUATLD Conference; 2014.
29.
go back to reference McAdam JM, Bucher SJ, Brickner PW, Vincent RL, Lascher S. Latent tuberculosis and active tuberculosis disease rates among the homeless, New York, New York, USA, 1992-2006. Emerg Infect Dis. 2009;15:1109–11.CrossRefPubMedPubMedCentral McAdam JM, Bucher SJ, Brickner PW, Vincent RL, Lascher S. Latent tuberculosis and active tuberculosis disease rates among the homeless, New York, New York, USA, 1992-2006. Emerg Infect Dis. 2009;15:1109–11.CrossRefPubMedPubMedCentral
30.
go back to reference Bock NN, Metzger BS, Tapia JR, Blumberg HM. A tuberculin screening and isoniazid preventive therapy program in an inner-city population. Am J Respir Crit Care Med. 1999;159:295–300.CrossRefPubMed Bock NN, Metzger BS, Tapia JR, Blumberg HM. A tuberculin screening and isoniazid preventive therapy program in an inner-city population. Am J Respir Crit Care Med. 1999;159:295–300.CrossRefPubMed
31.
go back to reference Kimerling ME, Shakes CF, Carlisle R, Lok KH, Benjamin WH, Dunlap NE. Spot sputum screening: evaluation of an intervention in two homeless shelters. Int J Tuberc Lung Dis. 1999;3:613–9.PubMed Kimerling ME, Shakes CF, Carlisle R, Lok KH, Benjamin WH, Dunlap NE. Spot sputum screening: evaluation of an intervention in two homeless shelters. Int J Tuberc Lung Dis. 1999;3:613–9.PubMed
32.
go back to reference Falchook G, Gaffga C, Eve S, Ali J. Tuberculosis screening, referral, and treatment in an inner city homeless shelter in Orleans parish. J Louisiana State Med Soc. 2000;152:398–404. Falchook G, Gaffga C, Eve S, Ali J. Tuberculosis screening, referral, and treatment in an inner city homeless shelter in Orleans parish. J Louisiana State Med Soc. 2000;152:398–404.
33.
go back to reference Kong PM, Tapy J, Calixto P, Burman WJ, Reves RR, Yang Z, Cave MD. Skin-test screening and tuberculosis transmission among the homeless. Emerg Infect Dis. 2002;8:1280–4.CrossRefPubMedPubMedCentral Kong PM, Tapy J, Calixto P, Burman WJ, Reves RR, Yang Z, Cave MD. Skin-test screening and tuberculosis transmission among the homeless. Emerg Infect Dis. 2002;8:1280–4.CrossRefPubMedPubMedCentral
34.
go back to reference Centers for Disease Control. Prevention and control of tuberculosis in U.S. communities with at-risk minority populations. Recommendations of the advisory Council for the Elimination of tuberculosis. MMWR Recommend Reports. 1992;41:1–11. Centers for Disease Control. Prevention and control of tuberculosis in U.S. communities with at-risk minority populations. Recommendations of the advisory Council for the Elimination of tuberculosis. MMWR Recommend Reports. 1992;41:1–11.
35.
go back to reference Miramontes R, Hill AN, Yelk Woodruff RS, Lambert LA, Navin TR, Castro KG, LoBue PA. Tuberculosis infection in the United States: prevalence estimates from the National Health and nutrition examination survey, 2011-2012. PLoS One. 2015;10:e0140881.CrossRefPubMedPubMedCentral Miramontes R, Hill AN, Yelk Woodruff RS, Lambert LA, Navin TR, Castro KG, LoBue PA. Tuberculosis infection in the United States: prevalence estimates from the National Health and nutrition examination survey, 2011-2012. PLoS One. 2015;10:e0140881.CrossRefPubMedPubMedCentral
36.
go back to reference Centers for Disease Control and Prevention. Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR Morb Mortal Wkly Rep. 2011;60:1650–3. Centers for Disease Control and Prevention. Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR Morb Mortal Wkly Rep. 2011;60:1650–3.
37.
go back to reference Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med. 2011;365:2155–66.CrossRefPubMed Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med. 2011;365:2155–66.CrossRefPubMed
38.
go back to reference Moro RN, Sterling TR, Saukkonen J, Vernon A, Horsburgh CR, Chaisson RE, Hamilton CD, Villarino ME, Goldberg S. Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial. Int J Tuberc Lung Dis. 2017;21:286–96.CrossRefPubMed Moro RN, Sterling TR, Saukkonen J, Vernon A, Horsburgh CR, Chaisson RE, Hamilton CD, Villarino ME, Goldberg S. Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial. Int J Tuberc Lung Dis. 2017;21:286–96.CrossRefPubMed
39.
go back to reference Alsdurf H, Hill PC, Matteelli A, Getahun H, Menzies D. The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16:1269–78.CrossRefPubMed Alsdurf H, Hill PC, Matteelli A, Getahun H, Menzies D. The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16:1269–78.CrossRefPubMed
40.
go back to reference Sandul AL, Nwana N, Holcombe JM, Lobato MN, Marks S, Webb R, Wang SH, Stewart B, Griffin P, Hunt G, et al. High rate of treatment completion in program settings with 12-dose weekly isoniazid and rifapentine (3HP) for latent Mycobacterium tuberculosis infection. Clin Infect Dis. 2017; https://doi.org/10.1093/cid/cix505. Sandul AL, Nwana N, Holcombe JM, Lobato MN, Marks S, Webb R, Wang SH, Stewart B, Griffin P, Hunt G, et al. High rate of treatment completion in program settings with 12-dose weekly isoniazid and rifapentine (3HP) for latent Mycobacterium tuberculosis infection. Clin Infect Dis. 2017; https://​doi.​org/​10.​1093/​cid/​cix505.
42.
go back to reference Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64:e1–e33.CrossRefPubMed Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64:e1–e33.CrossRefPubMed
43.
go back to reference U. S. Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Bauman L, Davidson KW, Epling JW Jr, Garcia FA, Herzstein J, Kemper AR, et al. Screening for latent tuberculosis infection in adults: US preventive services task force recommendation statement. JAMA. 2016;316:962–9.CrossRef U. S. Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Bauman L, Davidson KW, Epling JW Jr, Garcia FA, Herzstein J, Kemper AR, et al. Screening for latent tuberculosis infection in adults: US preventive services task force recommendation statement. JAMA. 2016;316:962–9.CrossRef
44.
go back to reference Khan K, Wang J, Hu W, Bierman A, Li Y, Gardam M. Tuberculosis infection in the United States: national trends over three decades. Am J Respir Crit Care Med. 2008;177:455–60.CrossRefPubMed Khan K, Wang J, Hu W, Bierman A, Li Y, Gardam M. Tuberculosis infection in the United States: national trends over three decades. Am J Respir Crit Care Med. 2008;177:455–60.CrossRefPubMed
Metadata
Title
Care Cascade for targeted tuberculosis testing and linkage to Care in Homeless Populations in the United States: a meta-analysis
Authors
Andrea Parriott
Mohsen Malekinejad
Amanda P. Miller
Suzanne M. Marks
Hacsi Horvath
James G. Kahn
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2018
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-018-5393-x

Other articles of this Issue 1/2018

BMC Public Health 1/2018 Go to the issue